Phio Pharmaceuticals (PHIO) Equity Ratio (2016 - 2021)
Phio Pharmaceuticals' Equity Ratio history spans 10 years, with the latest figure at 0.9 for Q3 2021.
- For Q3 2021, Equity Ratio rose 6.64% year-over-year to 0.9; the TTM value through Sep 2021 reached 0.9, up 6.64%, while the annual FY2020 figure was 0.83, 15.67% up from the prior year.
- Equity Ratio reached 0.9 in Q3 2021 per PHIO's latest filing, down from 0.91 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.93 in Q1 2021 to a low of 0.18 in Q1 2018.
- Average Equity Ratio over 5 years is 0.73, with a median of 0.8 recorded in 2019.
- Peak YoY movement for Equity Ratio: crashed 76.61% in 2018, then skyrocketed 364.65% in 2019.
- A 5-year view of Equity Ratio shows it stood at 0.45 in 2017, then skyrocketed by 98.12% to 0.89 in 2018, then fell by 19.31% to 0.72 in 2019, then rose by 15.67% to 0.83 in 2020, then grew by 9.24% to 0.9 in 2021.
- Per Business Quant, the three most recent readings for PHIO's Equity Ratio are 0.9 (Q3 2021), 0.91 (Q2 2021), and 0.93 (Q1 2021).